Prostaglandin E1 as Treatment for Erectile Failure in Elderly Men

  • Michael F. Godschalk*
  • , Juza Chen
  • , P. Gary Katz
  • , Thomas Mulligan
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

OBJECTIVE: To determine the efficacy of intracavernosal injection of prostaglandin E1(alprostadil) in elderly men with erectile failure. DESIGN: Prospective study. SETTING: Outpatients at a university‐affiliated VA Medical Center. PARTICIPANTS: Ten subjects aged 65 years and older with duration of erectile failure of 6 months or longer. INTERVENTIONS: Subjects received intracavernosal injections of prostaglandin E1in the office and self‐administered intracavernosal prostaglandin E1at home. MEASUREMENTS: Penile rigidity was measured by palpation and by the Rigiscan rigidity monitor. RESULTS: Intracavernosal injection of prostaglandin E1produced erections adequate for intercourse in 9 of the 10 subjects. Attempts at intercourse were rated satisfactory by two‐thirds of the subjects and their spouses. CONCLUSIONS: Intracavernosal injection of prostaglandin E1is safe and effective for erectile failure in elderly men. 1994 The American Geriatrics Society

Original languageEnglish
Pages (from-to)1263-1265
Number of pages3
JournalJournal of the American Geriatrics Society
Volume42
Issue number12
DOIs
StatePublished - Dec 1994
Externally publishedYes

Fingerprint

Dive into the research topics of 'Prostaglandin E1 as Treatment for Erectile Failure in Elderly Men'. Together they form a unique fingerprint.

Cite this